Last 12 months
Inside the activity.
0 purchase rows · 0 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 10, 2017 Filed Feb 15, 2017 01:34 UTC |
IVASCYN DANIEL JSee Remarks
|
OtherCOMMON STOCK | 10,081 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-010907 · doc4.xml · nonDerivative · entry 1 IVASCYN DANIEL J · CIK 0001201895 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,081 F1 · kind: Represents transfer of shares by the Reporting Person to a family member. F2 · balance_after: The aggregate holdings reported on Line 1, Table I, include 481 shares acquired on various dates by the Reporting Person under a qualified dividend reinvestment plan. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.